Skip to main content

Sirolimus

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

  • RegistryNCT07581704
  • PhasePhase 1
  • StatusRecruiting
  • ConditionMultiple Myeloma
  • SponsorChristopher Strouse
How Sirolimus worksNCT075817041 min

What the film says

Read the transcript

This trial is for relapsed or refractory multiple myeloma in adults who were previously exposed to T cell engager therapy.

The idea: prepare the immune system first. Patients receive short pre conditioning with sirolimus before a T cell engaging bispecific antibody, teclistamab or talquetamab. The study tests safety, and whether pre conditioning changes the ratio of effector to exhausted T cells.

This is a single center phase 1b study of 10 patients. At the University of Iowa in Iowa City, Christopher Strouse leads it.

Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT07581704

    Relapsed or refractory multiple myeloma, adults previously exposed to T cell engager therapy; Short pre conditioning with sirolimus before a T cell engaging bispecific antibody, teclistamab or talquetamab; Tests safety and whether pre conditioning changes the effector to exhausted T cell ratio; Single center phase 1b, 10 patients (+1 more lines)

The drug

What is being tested.

Sirolimus is an immunosuppressant drug. Sirolimus binds to FK binding protein 12 and inhibits mTOR. This then suppresses T-cell proliferation and inhibits progression from G1 to S phase of the cell cycle.

Teclistamab is a bispecific antibody that binds the CD3 receptor on T-cells and the B-cell maturation antigen on multiple myeloma cells and healthy B-lineage cells.

This is a Phase Ib trial with expansion cohort to assess the safety and estimate the preliminary efficacy of sirolimus pre-conditioning prior to treatment with a T-cell engaging bispecific antibody in patients with relapsed / refractory multiple myeloma previously exposed to T-cell engager therapy.

The study

How the trial runs.

This is a single center, single arm Phase Ib study with expansion cohort designed to establish the safety and physiologic effects of sirolimus pre-conditioning followed by T-cell engaging bispecific antibody therapy.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Willingness and ability to provide signed and dated informed consent form.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Aged 18 years of older.
  • Diagnosis with multiple myeloma, per IMWG Consensus Criteria.20
  • Planned for treatment with teclistamab, or talquetamab per standard of care, label indications.15

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.